Month: May 2022

Genmab Announces Financial Results for the First Quarter of 2022

Written by Customer Service on May 11, 2022. Posted in Earnings Releases And Operating Results.

May 11, 2022 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2022 HighlightsDARZALEX® net sales as reported by Johnson & Johnson increased 36% compared to the first three months of 2021 to USD 1,856 million, resulting in royalty revenue of DKK 1,501 million Genmab updates its 2022 financial guidance“During the first quarter of 2022, there were continued advancements in our pipeline, including the first patient dosed with DuoBody®-CD3xB7H4 (GEN1047), the presentation of data from the tisotumab vedotin innovaTV 207 study, and the U.S. Food and Drug Administration (U.S. FDA) granting orphan-drug designation to epcoritamab for the treatment of follicular lymphoma (FL). Together these events help to progress us further in our evolution into a fully integrated biotech innovation powerhouse,” said Jan van de...

GOGL – Invitation to presentation of Q1 2022 Results

Written by Customer Service on May 11, 2022. Posted in Public Companies.

Golden Ocean Group Limited will publish its financial results for the first quarter of 2022 on Thursday May 19, 2022. In connection with the release, a teleconference/webcast will be held as described below: Teleconference and webcastA conference call will be held at 3:00 P.M. CET (09:00 A.M. New York Time) on Thursday May 19, 2022. The presentation will be available for download from the Investor Relations section at www.goldenocean.bm (under “Presentations”) prior to the teleconference/webcast. In order to listen to the presentation you may do one of the following: a. WebcastClick the “Webcast” link on www.goldenocean.bm b. Conference CallPARTICIPANTS DIAL IN TELEPHONE NUMBERSInternational Dial-In: +44 (0) 2071 92 8338United Kingdom Toll Free: 08002796619Norway Toll Free: 800 56 865US Toll-Free: +1 877...

Correction: Form 8.3 – Hibernia REIT plc

Written by Customer Service on May 11, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) State Street Global Advisors & AffiliatesCompany dealt in Hibernia REIT plcClass of relevant security to which the dealings being disclosed relate (Note 2) €0.10 ordinary sharesDate of dealing 05th May 2022 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 17,694,1382.67359% (2) Derivatives (other than options) N/A N/A (3) Options and agreements to purchase/sell N/A N/A Total 17,694,138...

Correction: Form 8.3 – Hibernia REIT plc

Written by Customer Service on May 11, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) State Street Global Advisors & AffiliatesCompany dealt in Hibernia REIT plcClass of relevant security to which the dealings being disclosed relate (Note 2) €0.10 ordinary sharesDate of dealing 06th May 2022 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 17,766,995 2.68460% (2) Derivatives (other than options) N/A N/A (3) Options and agreements to purchase/sell N/A N/A Total 17,766,995 2.68460%...

OptimumBank Holdings, Inc. (OPHC-NASDAQ) Announces Resignation of Board Member

Written by Customer Service on May 11, 2022. Posted in Public Companies.

Fort Lauderdale, FL, May 11, 2022 (GLOBE NEWSWIRE) — Heng Fai Ambrose Chan has informed the Boards of OptimumBank (the “Bank”) and OptimumBank Holding, Inc. (the “Company”) that he will resign from both Boards effective as of April 30, 2022. In his letter of resignation, Mr. Chan, who resides in Singapore, noted that he was regrettably stepping down due to the time difference and his workload. Mr. Chan served as a Director of the Bank and Company since June 2018. During his time on the Boards, Mr. Chan helped create a path for the Bank and Company to recover from legacy regulatory issues, leaving the Bank with a strong capital structure, explosive growth and a bright future. Over the past four years, the Bank’s balance sheet has grown tremendously with a significant increase to its loan portfolio as well as deposits. In addition...

Brookmount Explorations, Inc. Financial Results Commentary and Shareholder Update

Written by Customer Service on May 11, 2022. Posted in Public Companies.

Reno, NV, May 11, 2022 (GLOBE NEWSWIRE) — Brookmount Explorations, Inc. (OTC PINK: BMXI) (“Brookmount”), a Nevada incorporated company, is pleased to provide this update to shareholders on its financial results for the 1st quarter and an update on operations. The Company has filed its financial results for the quarter ended 2/28/2022. Highlights included:The Company recorded exceptional operating results for the first quarter with net profit of $1.9 million, compared with $1.3 million for the comparable period in the prior year, an increase of 40%. Revenue for the quarter was $4 million, up by 25% over the corresponding period in 2021.This increase in net earnings reflected continued extraction and processing of ore carrying higher grades, at our Talawaan operation, which continues to be the backbone of gold...

Entrada Therapeutics Presents New Data Supporting its Growing Pipeline of Endosomal Escape Vehicle (EEV™) Therapeutics at TIDES USA 2022

Written by Customer Service on May 11, 2022. Posted in Public Companies.

Figure 1 A single IV dose of ENTR-601-44 resulted in robust exon skipping in both skeletal and cardiac muscles in NHP, as well as prolonged duration of effect for at least 12 weeksNew non-human primate data demonstrate a durability of response through 12 weeks for lead clinical candidate, ENTR-601-44, for the potential treatment of Duchenne muscular dystrophy Second clinical candidate, ENTR-701, announced for the potential treatment of myotonic dystrophy type 1 On track to submit Investigational New Drug applications to the U.S. Food and Drug Administration for ENTR-601-44 targeting Duchenne muscular dystrophy in Q4 2022 and for ENTR-701 targeting myotonic dystrophy type 1 in 2023 BOSTON, May 11, 2022 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of...

FDCTech’s Quarterly Release for the First Quarter (FY22 Q2) Results

Written by Customer Service on May 11, 2022. Posted in Public Companies.

The increase in revenue by 2,294.79% after the successful acquisition of AD Advisory Services Pty Ltd. The Company continues to build on its technology-driven acquisition growth strategy and is confident that the recent market correction may provide opportunities for more strategic acquisition targets. Irvine, CA, May 11, 2022 (GLOBE NEWSWIRE) — FDCTech, Inc. (“FDC” or the “Company,” OTCQB: FDCT), a fintech-driven company specializing in buying and integrating small to mid-size legacy financial services companies, today announced the following results for the quarter ended March 31, 2022, as compared to the corresponding period of last fiscal year:The revenues generated for the three months ended March 31, 2022, and 2021 were $1,541,122 and $64,353, respectively.The increase in revenue by 2,294.79% results...

Gain Therapeutics Presents Positive Preclinical Data On Its Gaucher Disease Program at IWGGD Symposium

Written by Customer Service on May 11, 2022. Posted in Public Companies.

Lead compound GT-02329 increases GCase levels and activity, depletes toxic substrates glucosylceramide (GlcCer) and glucosylsphingosine (GlcSph) in relevant Gaucher disease (GD) models BETHESDA, Md., May 11, 2022 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming drug discovery with its proprietary computational discovery platform identifying novel allosteric binding sites and creating small molecule treatments, today presented additional confirmatory data from its Gaucher disease program. The results were highlighted in an oral presentation at the 1st IWGDD Symposium being held May 8-11, 2022, in the Netherlands. The data show that the tested compounds increase the levels and activity of the beta-glucocerebrosidase (GCase) protein, increase co-localization...

Risk Strategies Acquires The Insurance Center of Central Florida

Written by Customer Service on May 11, 2022. Posted in Mergers And Acquisitions.

Strengthens presence, specialty capabilities in central part of the state BOSTON, May 11, 2022 (GLOBE NEWSWIRE) — Risk Strategies, a leading national specialty insurance brokerage and risk management firm, today announced it has acquired The Insurance Center of Central Florida (ICCF), a firm primarily focused on crafting risk management solutions for private clients. Terms of the deal were not announced. Headquartered in Melbourne, Florida, ICCF was founded 31 years ago by its president and owner Frank Hanrahan and is a member of the Florida Association of Insurance Agents and Professional Insurance Agents. The firm offers property and casualty insurance for homes and vehicles and provides coverages and risk management advice for area businesses. “As we build our presence and client services capabilities in Florida, we saw ICCF...

Month: May 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals